BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth

Abstract

Our findings demonstrate that macrophages play a critical role in melanoma resistance to BRAFi, suggesting that targeting macrophages will benefit patients with BRAF-mutant melanoma.